Ken Griffin Certara, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.46 - $16.58 $34,518 - $54,713	3,300 Added 20.75%	19,200 $224,000
Q2 2024 Aug 14, 2024	BUY	$13.36 - $18.94 $172,344 - $244,326	12,900 Added 430.0%	15,900 $220,000
Q1 2024 May 15, 2024	BUY	$15.65 - $19.45 $14,085 - $17,505	900 Added 42.86%	3,000 $53,000
Q4 2023 Feb 14, 2024	SELL	$12.12 - $18.19 $10,908 - $16,371	-900 Reduced 30.0%	2,100 $36,000
Q3 2023 Nov 14, 2023	SELL	$13.9 - $19.58 $2,780 - $3,915	-200 Reduced 6.25%	3,000 $43,000
Q2 2023 Aug 14, 2023	SELL	$16.89 - $24.64 $15,201 - $22,176	-900 Reduced 21.95%	3,200 $58,000
Q1 2023 May 15, 2023	BUY	$15.9 - $24.72 $25,440 - $39,552	1,600 Added 64.0%	4,100 $98,000
Q4 2022 Feb 14, 2023	BUY	$10.7 - $17.84 $26,750 - $44,600	2,500 New	2,500 $40,000

233

105M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.71B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.